Eliem Therapeutics (CLYM) P/E (2021 - 2026)
Eliem Therapeutics (CLYM) P/E from Sep 30, 2021 to Jul 21, 2026. The TTM Eliem Therapeutics (CLYM) P/E is -13.49. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Eliem Therapeutics (CLYM)
| Year | P/E | Change |
|---|---|---|
| 2026 | -13.49 | +234.34% |
| 2025 | -4.04 | +155.71% |
| 2024 | -1.58 | -14.88% |
| 2023 | -1.85 | -8.69% |
| 2022 | -2.03 | -85.18% |
| 2021 | -13.70 | N/A |
Comparison Eliem Therapeutics (CLYM) P/E with competitors
Eliem Therapeutics (CLYM) P/E is -13.49.